• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝塞斯达III类甲状腺结节的风险分层:一家地区性医疗保健医院的经验

Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital.

作者信息

Al Dawish Mohamed, Alwin Robert Asirvatham, Al Shehri Khalid, Hawsawi Salwa, Mujammami Muhammad, Al Basha Ibrahim Ali, Alrasheed Mohannad, Asiri Shuaa, Alzouman Muneerah, Alkharashi Eyad

机构信息

Department of Endocrinology, Prince Sultan Military Medical City, Riyadh, SAU.

Division of Endocrinology and Metabolism, Department of Medicine, King Saud University, Riyadh, SAU.

出版信息

Cureus. 2020 May 19;12(5):e8202. doi: 10.7759/cureus.8202.

DOI:10.7759/cureus.8202
PMID:32455091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7241230/
Abstract

Background The Bethesda System for Reporting Thyroid Cytolopathology (TBSRTC) is the standardized category-based reporting system for thyroid nodule (TN) aspirations; however, atypia of undetermined significance/follicular lesion of undetermined significance (Bethesda category III, AUS/FLUS) is the most controversial category. The aim of this study was to identify the degree of malignancy risk and the related risk factors in the surgical pathology of the Bethesda Category III thyroid nodules.  Methods A total of 4074 patients (15-90 years, 81.5% of females) were subjected to retrospective analysis, and a total of 463 nodules were classified as Bethesda Class III and included in the analysis. Once all the thyroid cytopathological slides and ultrasound (US) reports were reviewed, they were classified according to the Bethesda System for Reporting Thyroid Cytology, the American College of Radiology (ACR) and the Thyroid Imaging Reporting and Data System (TI-RADS). Results Among the 463 Bethesda class III nodules, 167 nodules were surgically excised, showing an overall malignancy of 27.6% (n = 46/167). Patients having thyroid-stimulating hormone (TSH) levels of >4.5 mIU/L (35%), TN <2 cm (34.6%), solid or nearly solid (28.7%), highly hypoechoic (58.3%), longer than wide (50%), lobulated (45.5%), punctate echogenic (48.6%), ACR TI-RAD 5 (55.2%) and falling under the ATA category of high suspicion (50%), displayed a higher risk of malignancy (ROM). The chi-square test revealed a strong association between the echogenicity, echogenic foci, ACR TI-RAD and American Thyroid Association (ATA) category between the malignant and benign nodules. The papillary thyroid carcinoma (PTC) follicular variant (39%) and PTC classical (27%) were identified, in this study population, as the commonest forms of thyroid cancer. Conclusion The nodules with AUS/FLUS cytology malignancy rate are comparable with the earlier estimations of other countries. The ACR TI-RAD displayed more accurate diagnostic performances in predicting malignancy in the Bethesda III nodules. However, to confirm the accuracy of the molecular marker tests in specific cytological scenarios, more extensive studies are required in the future.

摘要

背景 甲状腺细胞病理学报告的贝塞斯达系统(TBSRTC)是甲状腺结节(TN)细针穿刺抽吸的标准化分类报告系统;然而,意义不明确的非典型性/意义不明确的滤泡性病变(贝塞斯达Ⅲ类,AUS/FLUS)是最具争议的类别。本研究的目的是确定贝塞斯达Ⅲ类甲状腺结节手术病理中的恶性风险程度及相关危险因素。方法 对4074例患者(15 - 90岁,女性占81.5%)进行回顾性分析,共有463个结节被分类为贝塞斯达Ⅲ类并纳入分析。在复查所有甲状腺细胞病理切片和超声(US)报告后,根据甲状腺细胞病理学报告的贝塞斯达系统、美国放射学会(ACR)和甲状腺影像报告和数据系统(TI - RADS)进行分类。结果 在463个贝塞斯达Ⅲ类结节中,167个结节接受了手术切除,总体恶性率为27.6%(n = 46/167)。促甲状腺激素(TSH)水平>4.5 mIU/L的患者(35%)、TN<2 cm的患者(34.6%)、实性或近实性结节(28.7%)、高回声减低结节(58.3%)、长径大于短径的结节(50%)、分叶状结节(45.5%)、点状强回声结节(48.6%)、ACR TI - RAD 5类结节(55.2%)以及美国甲状腺协会(ATA)高度可疑类别的结节(50%),其恶性风险(ROM)更高。卡方检验显示,恶性结节与良性结节在回声、回声灶、ACR TI - RAD和ATA分类之间存在强关联。在本研究人群中,甲状腺乳头状癌(PTC)滤泡变异型(39%)和PTC经典型(27%)是最常见的甲状腺癌类型。结论 AUS/FLUS细胞学的结节恶性率与其他国家早期的估计相当。ACR TI - RAD在预测贝塞斯达Ⅲ类结节的恶性方面表现出更准确的诊断性能。然而,为了在特定细胞学情况下确认分子标志物检测的准确性,未来需要进行更广泛的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/e8e0b7c9af19/cureus-0012-00000008202-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/4c494903964e/cureus-0012-00000008202-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/d798f8c5d94f/cureus-0012-00000008202-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/e8e0b7c9af19/cureus-0012-00000008202-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/4c494903964e/cureus-0012-00000008202-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/d798f8c5d94f/cureus-0012-00000008202-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7989/7241230/e8e0b7c9af19/cureus-0012-00000008202-i03.jpg

相似文献

1
Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital.贝塞斯达III类甲状腺结节的风险分层:一家地区性医疗保健医院的经验
Cureus. 2020 May 19;12(5):e8202. doi: 10.7759/cureus.8202.
2
Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.应用 TIRADS 和 Bethesda 分类对甲状腺不典型意义结节/滤泡性病变不明意义的良恶性进行临床-细胞病理亚分类。
Front Endocrinol (Lausanne). 2023 May 29;14:1135196. doi: 10.3389/fendo.2023.1135196. eCollection 2023.
3
USING THE ATA AND ACR TI-RADS SONOGRAPHIC CLASSIFICATIONS AS ADJUNCTIVE PREDICTORS OF MALIGNANCY FOR INDETERMINATE THYROID NODULES.使用美国甲状腺协会和 ACR 甲状腺影像报告和数据系统超声分类作为不确定甲状腺结节恶性肿瘤的辅助预测因子。
Endocr Pract. 2019 Sep;25(9):908-917. doi: 10.4158/EP-2018-0559. Epub 2019 Jun 6.
4
Individual Ultrasonographic Characteristics of Thyroid Nodules and Their Cytopathological Correlation to Determine Malignancy Risk.甲状腺结节的个体超声特征及其与细胞病理学的相关性以确定恶性风险。
Cureus. 2024 Jul 5;16(7):e63918. doi: 10.7759/cureus.63918. eCollection 2024 Jul.
5
Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.甲状腺结节的管理:促甲状腺激素、超声及用于预测恶性肿瘤的细胞学分类系统
Cancer Inform. 2018 Mar 19;17:1176935118765132. doi: 10.1177/1176935118765132. eCollection 2018.
6
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
7
Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience.甲状腺结节在细胞学上分类为贝塞斯达Ⅲ类的评估及其恶性率:一项机构经验。
Cytojournal. 2019 Sep 16;16:18. doi: 10.4103/cytojournal.cytojournal_4_19. eCollection 2019.
8
The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules.甲状腺影像报告和数据系统对贝塞斯达Ⅲ级甲状腺结节管理的影响。
J Taibah Univ Med Sci. 2022 Nov 14;18(3):506-511. doi: 10.1016/j.jtumed.2022.10.009. eCollection 2023 Jun.
9
Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.美国放射学院甲状腺影像报告和数据系统(ACR TI-RADS)评分较高是否预示恶性风险增加?评估甲状腺结节时 ACR TI-RADS 与细针穿刺细胞学的相关性研究。
Cancer Cytopathol. 2020 Jul;128(7):470-481. doi: 10.1002/cncy.22254. Epub 2020 Feb 20.
10
Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.使用2015年美国甲状腺协会(ATA)指南定义的超声模式对具有意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS)细胞学特征的甲状腺结节进行风险分层。
Ann Otol Rhinol Laryngol. 2017 Sep;126(9):625-633. doi: 10.1177/0003489417719472. Epub 2017 Jul 18.

引用本文的文献

1
The Role of Ultrasound as a Predictor of Malignancy in Indeterminate Thyroid Nodules-A Multicenter Study.超声作为甲状腺不确定结节恶性预测指标的作用——一项多中心研究
Medicina (Kaunas). 2025 Jun 12;61(6):1082. doi: 10.3390/medicina61061082.
2
Serum thyroid-stimulating hormone as a diagnostic marker for cancer in atypia of undetermined significance/follicular lesion of undetermined significance nodules.血清促甲状腺激素作为意义不明确的非典型增生/意义不明确的滤泡性病变结节中癌症的诊断标志物。
Gland Surg. 2025 Apr 30;14(4):618-627. doi: 10.21037/gs-2024-520. Epub 2025 Apr 25.
3
Diagnostic performance of ultrasound risk stratification systems on thyroid nodules cytologically classified as indeterminate: a systematic review and meta-analysis.

本文引用的文献

1
Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance.具有非典型性或意义未明的滤泡性病变的甲状腺结节的恶性率
Int Arch Otorhinolaryngol. 2020 Apr;24(2):e221-e226. doi: 10.1055/s-0039-1698784. Epub 2020 Jan 28.
2
Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience.甲状腺结节在细胞学上分类为贝塞斯达Ⅲ类的评估及其恶性率:一项机构经验。
Cytojournal. 2019 Sep 16;16:18. doi: 10.4103/cytojournal.cytojournal_4_19. eCollection 2019.
3
The relationship of thyroid nodule size on malignancy risk according to histological type of thyroid cancer.
超声风险分层系统对细胞学分类为不确定的甲状腺结节的诊断性能:一项系统评价和荟萃分析
Ultrasonography. 2023 Oct;42(4):518-531. doi: 10.14366/usg.23055. Epub 2023 Jun 18.
4
Current controversies in the management of patients with indeterminate thyroid nodules.目前对甲状腺结节患者管理的争议。
Saudi Med J. 2023 Jul;44(7):633-639. doi: 10.15537/smj.2023.44.7.2023-0049.
5
The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules.甲状腺影像报告和数据系统对贝塞斯达Ⅲ级甲状腺结节管理的影响。
J Taibah Univ Med Sci. 2022 Nov 14;18(3):506-511. doi: 10.1016/j.jtumed.2022.10.009. eCollection 2023 Jun.
6
An artificial intelligence ultrasound system's ability to distinguish benign from malignant follicular-patterned lesions.人工智能超声系统区分滤泡样良性与恶性病变的能力。
Front Endocrinol (Lausanne). 2022 Oct 31;13:981403. doi: 10.3389/fendo.2022.981403. eCollection 2022.
7
Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis.AUS/FLUS甲状腺结节诊断患者术前TSH血清水平与甲状腺癌发生情况的评估
Biomedicines. 2022 Aug 8;10(8):1916. doi: 10.3390/biomedicines10081916.
8
Clinical and ultrasonographic features in cancer risk stratification of indeterminate thyroid nodules.临床和超声特征在不确定甲状腺结节的癌症风险分层中的作用。
Saudi Med J. 2022 May;43(5):473-478. doi: 10.15537/smj.2022.43.5.20220045.
9
The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk.甲状腺结节分类为贝塞斯达系统III类(AUS/FLUS)时恶性风险的预测以及超声检查结果在预测恶性风险中的作用。
Cureus. 2021 Sep 13;13(9):e17924. doi: 10.7759/cureus.17924. eCollection 2021 Sep.
根据甲状腺癌组织学类型,甲状腺结节大小与恶性风险的关系。
Acta Radiol. 2020 May;61(5):620-628. doi: 10.1177/0284185119875642. Epub 2019 Sep 25.
4
. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules.TIRADS在预测贝塞斯达系统I、III和V类结节中的甲状腺乳头状癌方面的应用
Cancer Biol Med. 2019 Feb;16(1):131-138. doi: 10.20892/j.issn.2095-3941.2018.0291.
5
Risk of Malignancy in Thyroid Nodules Using the American College of Radiology Thyroid Imaging Reporting and Data System in the NIFTP Era.在NIFTP时代使用美国放射学会甲状腺影像报告和数据系统评估甲状腺结节的恶性风险
Horm Metab Res. 2018 Oct;50(10):735-737. doi: 10.1055/a-0743-7326. Epub 2018 Oct 12.
6
Malignancy rates for Bethesda III subcategories in thyroid fine needle aspiration biopsy (FNAB).甲状腺细针穿刺活检(FNAB)中贝塞斯达III类亚类的恶性率。
Clinics (Sao Paulo). 2018;73:e370. doi: 10.6061/clinics/2018/e370. Epub 2018 May 28.
7
Increased Cancer Risk in Younger Patients with Thyroid Nodules Diagnosed as Atypia of Undetermined Significance.甲状腺结节被诊断为意义未明的非典型病变的年轻患者癌症风险增加。
Cureus. 2018 Mar 19;10(3):e2348. doi: 10.7759/cureus.2348.
8
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in thyroid tumor classification.甲状腺肿瘤分类中的具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)
Pathol Int. 2018 Jun;68(6):327-333. doi: 10.1111/pin.12673. Epub 2018 Apr 19.
9
The surgery and repeat aspiration outcomes of the atypia of undetermined significance/follicular lesion of undetermined significance category in The Bethesda System for Reporting Thyroid Cytopathology.《甲状腺细胞病理学报告系统-贝塞斯达系统》中不典型意义不明/滤泡性病变意义不明类别中手术和重复抽吸的结果。
Asian J Surg. 2019 Jan;42(1):144-147. doi: 10.1016/j.asjsur.2018.02.008. Epub 2018 Apr 11.
10
Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.甲状腺结节的管理:促甲状腺激素、超声及用于预测恶性肿瘤的细胞学分类系统
Cancer Inform. 2018 Mar 19;17:1176935118765132. doi: 10.1177/1176935118765132. eCollection 2018.